Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Novartis Set 'Responsible' Price For Kymriah, Express Scripts Says

Sep 13 2017

• By Cathy Kelly

Decorin protein

Related Content

Gene Therapy Reimbursement: Is Blindness A Bad First Test?

Jun 29 2017

Novartis Begins CAR-T Payment Experiments With Outcomes-Based Contract With CMS

Aug 31 2017

Novartis Beats CAR-T Competitors To The Pricing Punch With Kymriah Approval

Aug 31 2017

Related Companies

Novartis AG

Express Scripts Holding Company

Spark Therapeutics, Inc.

Pfizer Inc.

Additional Topics

United States Pricing Debate Reimbursement Policy Cancer BioPharmaceutical

More from Pricing Debate

More from Market Access

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window